These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1918785)

  • 21. Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.
    Krumpe PE; Cohn S; Garreltes J; Ramirez J; Coulter H; Haverstock D; Echols R
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():117-28. PubMed ID: 10225582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial.
    Mombelli G; Pezzoli R; Pinoja-Lutz G; Monotti R; Marone C; Franciolli M
    Arch Intern Med; 1999 Jan; 159(1):53-8. PubMed ID: 9892331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin in acute exacerbations of chronic bronchitis.
    Hoogkamp-Korstanje JA; Klein SJ
    J Antimicrob Chemother; 1986 Sep; 18(3):407-13. PubMed ID: 3490468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections.
    Wacha H; Warren B; Bassaris H; Nikolaidis P;
    Surg Infect (Larchmt); 2006 Aug; 7(4):341-54. PubMed ID: 16978077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of oral antibiotic treatment in nursing home-acquired pneumonia.
    Degelau J; Guay D; Straub K; Luxenberg MG
    J Am Geriatr Soc; 1995 Mar; 43(3):245-51. PubMed ID: 7884111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment guideline for nursing home-acquired pneumonia based on community practice.
    Naughton BJ; Mylotte JM
    J Am Geriatr Soc; 2000 Jan; 48(1):82-8. PubMed ID: 10642027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
    Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
    Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; Baur C
    Eur J Clin Microbiol; 1986 Apr; 5(2):226-31. PubMed ID: 2941287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.
    Höffken G; Barth J; Rubinstein E; Beckmann H;
    Infection; 2007 Dec; 35(6):414-20. PubMed ID: 18034211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: a pharmacoeconomic analysis.
    Amodio-Groton M; Madu A; Madu CN; Briceland LL; Seligman M; McMaster P; Miller MH
    Ann Pharmacother; 1996 Jun; 30(6):596-602. PubMed ID: 8792944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
    Izadi M; Dadsetan B; Najafi Z; Jafari S; Mazaheri E; Dadras O; Heidari H; SeyedAlinaghi S; Voltarelli F
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):228-239. PubMed ID: 30360748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections.
    Trenholme GM; Schmitt BA; Spear J; Gvazdinskas LC; Levin S
    Am J Med; 1989 Nov; 87(5A):116S-118S. PubMed ID: 2686411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy, safety and pharmacokinetics of intravenous ciprofloxacin in patients with lower respiratory tract infections.
    Ohmichi M; Hiraga Y
    J Int Med Res; 1999; 27(6):297-304. PubMed ID: 10726239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia].
    Toyonaga Y; Kanemura H; Kitano M; Mitsui Y; Ishihara T; Hoshiai M; Ohno R
    Jpn J Antibiot; 1999 Apr; 52(4):322-32. PubMed ID: 10396689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia. The Cefepime Study Group.
    Zervos M; Nelson M
    Antimicrob Agents Chemother; 1998 Apr; 42(4):729-33. PubMed ID: 9559773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone.
    Legua P; Lema J; Moll J; Jiang Q; Woods G; Friedland I
    Clin Ther; 2002 Mar; 24(3):434-44. PubMed ID: 11952026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.